NASDAQ:BGNE
Delisted

Beigene Stock Signals

etoro logo Buy BGNE
*Your capital is at risk
$184.71
+0 (+0%)
At Close: Mar 28, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for BeiGene Ltd

General

Signal Type Signal Value Data
Score 0.000 250 days ( -16.00 %
Last Price $184.71 0 %
Performance History
7 Days
$184.71 $184.71
0%
30 Days
$184.71 $184.71
0%
12 Mos
$156.39 $184.71
18.11%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $184.71 - $184.71
Trend - 3 mos 0.0464 % High Width: 0.473 %
Pred. range - 3 mos $183.98 - $184.85 Low -0.395 % - 0.0760 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Mar 27, 2025 - 2 days
RSI Short Pivot Signal Sell Very Low Jan 13, 2025 - 53 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Buy Medium Jan 27, 2025 - 44 days
Short/Long MA 3 mos Buy Medium Jan 27, 2025 - 44 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 46.06
Signal Type Signal Value Importance Data
Trend - 12 mos 20.72 % Very High Width: 54.99 %
Pred. range - 12 mos $208.76 - $323.56 High 13.02 % - 75.17 %
Short MA 12 mos Buy Very High Jan 03, 2025 - 58 days
Long MA 12 mos Sell Very High Dec 09, 2024 - 75 days
Short/Long MA 12 mos Sell Very High Dec 04, 2024 - 78 days
Pivot Long Sell Low Mar 27, 2025 - 2 days
RSI Long Pivot Signal Sell Low Jan 23, 2025 - 46 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT BEIGENE LTD
BeiGene
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonocyte leukemia, and acute myeloid leukemia; XGEVA to treat giant cell tu...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
5.49% Jun 12
GIB
$66.69
0.225% Jun 12
EAT
$140.46
9.32% Jun 05
TPR
$140.47
6.35% Jun 04
GLBE
$31.61
2.12% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE